Mc Ilrath & Eck, LLC Gilead Sciences, Inc. Transaction History

Mc Ilrath & Eck, LLC

$574 Million
Q3 2024

A detailed history of Mc Ilrath & Eck, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mc Ilrath & Eck, LLC holds 585 shares of GILD stock, worth $53,474. This represents 0.01% of its overall portfolio holdings.

Number of Shares

585

Previous 585 -0.0%

Holding current value

$53,474

Previous $40,000 22.5%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $12,377 - $14,284	-196 Reduced 25.1%	585 $40,000
Q1 2024 May 10, 2024	BUY	$71.58 - $87.29 $16,534 - $20,163	231 Added 42.0%	781 $57,000
Q4 2023 Feb 05, 2024	BUY	$73.27 - $83.09 $16,192 - $18,362	221 Added 67.17%	550 $44,000
Q3 2023 Nov 15, 2023	SELL	$73.94 - $80.67 $30,093 - $32,832	-407 Reduced 55.3%	329 $24,000
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $10,781 - $15,478	173 Added 30.73%	736 $63,000
Q3 2022 Oct 18, 2022	BUY	$59.54 - $68.01 $3,453 - $3,944	58 Added 11.49%	563 $35,000
Q2 2022 Jul 29, 2022	SELL	$57.72 - $65.01 $4,098 - $4,615	-71 Reduced 12.33%	505 $31,000
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $289 - $362	-5 Reduced 0.86%	576 $34,000
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $67 - $73	1 Added 0.17%	581 $41,000
Q2 2021 Aug 09, 2021	BUY	$63.47 - $69.35 $63 - $69	1 Added 0.17%	580 $40,000
Q4 2020 Feb 05, 2021	BUY	$56.65 - $64.55 $56 - $64	1 Added 0.17%	579 $34,000
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $745 - $936	12 Added 2.12%	578 $37,000
Q2 2020 Aug 04, 2020	BUY	$72.34 - $84.0 $6,799 - $7,896	94 Added 19.92%	566 $44,000
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $15,532 - $19,894	248 Added 110.71%	472 $35,000
Q3 2019 Nov 05, 2019	SELL	$62.51 - $69.0 $3,813 - $4,209	-61 Reduced 21.4%	224 $14,000
Q1 2019 May 07, 2019	BUY	$62.53 - $70.05 $62 - $70	1 Added 0.35%	285 $18,000
Q4 2018 May 07, 2019	SELL	$60.54 - $79.0 $1,937 - $2,528	-32 Reduced 10.13%	284 $18,000
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $3,706 - $4,103	52 Added 19.7%	316 $24,000
Q2 2018 Aug 07, 2018	SELL	$64.88 - $75.68 $54,693 - $63,798	-843 Reduced 76.15%	264 $19,000
Q1 2018 May 22, 2018	SELL	$72.84 - $88.8 $49,822 - $60,739	-684 Reduced 38.19%	1,107 $83,000
Q4 2017 Mar 19, 2018	BUY	$71.15 - $83.52 $127,429 - $149,584	1,791	1,791 $128,000

Others Institutions Holding GILD

# of Institutions

1,928

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Ilrath & Eck, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Ilrath & Eck, LLC with notifications on news.

Account